Convalescent Plasma Trial in COVID -19 Patients

NCT04356534 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV 2
COVID-19

Interventions

OTHER: plasma therapy using convalescent plasma with antibody against SARS-CoV-2
OTHER: Routine care for COVID-19 patients

Sponsor

Royal College of Surgeons in Ireland - Medical University of Bahrain

Collaborators

[object Object]
[object Object]
[object Object]